Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

efficacyAI Signs Exclusive Software License for MedicascyAItm a Suite of Deep Learning Algorithms Used to Predict Drug Safety and Efficacy


efficacyAI, Inc. announced today that it has recently signed a license agreement with the Georgia Tech Research Corporation granting it exclusive rights to the use of a suite of algorithms called MedicascyAI. This novel artificial intelligence software platform requires only the chemical structure of a small molecule as the input to make actionable high confidence predictions related to the safety and efficacy of the molecule's use for targeted indications.

"We are excited about making this new technology widely available to anyone who can benefit from it in today's evolving drug discovery marketplace," says CEO Tony Bellezza, "MedicascyAI provides a cost effective methodology to quickly identify molecules with high value predictions to pursue, or invest in, at the very beginning of the drug discovery or product development lifecycle. We plan to use MedicascyAI's analytical capabilities to accelerate life-changing solutions and to transform the way pharmaceutical, nutraceutical, supplement, and cannabis companies develop their products."

Highly confident MedicascyAI deep learning machine predictions can be used effectively by companies and investors to accelerate development timelines and to reduce the costs of their current drug discovery practices, or to repurpose or develop new nutraceutical and dietary supplement products.

About efficacyAI, Inc.

efficacyAI, Inc. is a biotechnology consulting company which uses its licensed algorithms to provide services to drug discovery companies, drug discovery investors, nutraceutical and supplement wholesalers and manufacturers, and cannabis industry stakeholders. The Company's artificial intelligence technology is used to accelerate development timelines and reduce costs associated with new and repurposed drug discovery efforts and new and repurposed dietary ingredient product line development. The Company's mantra is built around caring about people's health, life, and knowledge. The Company's administrative office is located in the greater Harrisburg, PA area and has active operations in Atlanta, GA and Kure Beach, NC. For more information, please visit www.efficacyai.com or contact us at info@efficacyai.com or 267.831.3408.


These press releases may also interest you

at 15:01
The Deputy Prime Minister, Chrystia Freeland, today announced that Canada and the United States have agreed to extend the temporary restriction of all non-essential travel across the Canada-U.S. border until September 21, 2020. The Government of...

at 15:00
There is no evidence to suggest that onions grown in Canada are associated with this outbreak. Onions imported from the United States are under investigation. Do not eat, use, sell or serve any red, white, yellow, and sweet yellow onions from Thomson...

at 15:00
Dr. Ravi Somayazula and Body By Ravi Plastic Surgery & Aesthetics is pleased to announce that they now have over 250 Google reviews, plus many five-star ratings on Yelp, RealSelf, and Facebook. Based on Dr. Ravi's outstanding client feedback,...

at 15:00
Aegle Nutrition, an industry leader and manufacturer of liquid dietary supplements, announced it received a closeout letter from the Food and Drug Administration (FDA). The letter, dated August 4, 2020, successfully closes out the FDA's 483 Warning...

at 14:30
Union Dental Holdings, Inc.  ? Union Dental Holdings, Inc. has announced another step forward in its effort to transparently restructure and transition into a new business model. The Company recently named forensic accountant Michael O'Shea to...

at 14:25
Lantern Pharma , a clinical stage biotechnology company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery and development, and identify patients who will benefit from its portfolio of targeted oncology...



News published on 9 july 2020 at 18:35 and distributed by: